BDBM603944 (Rac)-trans-3-Fluoropropyl 2-[[6-[[-2-(benzyloxymethyl)cyclopropyl]methoxy]-5-(3-hydroxyazetidin-1-yl)pyridine-2-carbonyl]amino]-2-ethyl-butanoate::US11655243, Example 22

SMILES CCC(CC)(NC(=O)c1ccc(N2CC(O)C2)c(OC[C@H]2C[C@@H]2COCc2ccccc2)n1)C(=O)OCCCF

InChI Key InChIKey=SBPLDHATYCZQMS-UHFFFAOYSA-N

Data  1 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 603944   

TargetCannabinoid receptor 2(Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM603944(US11655243, Example 22 | (Rac)-trans-3-Fluoropropy...)
Affinity DataKi:  755nMAssay Description:The affinity of the compounds of the invention for cannabinoid CB1 receptors was determined using recommended amounts of membrane preparations (Perki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2023
Entry Details
Go to US Patent